ライフサイエンスコーパス: adjusted analysis

1 o, 1.48; 95% confidence interval, 1.03-2.13; adjusted analysis).

2 that retained full coverage (P<0.001 for the adjusted analysis).

3 sits variation) of the untreated fellow eye (adjusted analysis).

4 [CI], 5.2-40.8;P= .0109, using a propensity-adjusted analysis).

5 Antibody responses were compared in adjusted analysis.

6 re TBI (HR 5 11.4, 95% CI 5 7.4-17.5) in age-adjusted analysis.

7 were tested using multivariate time-to-event adjusted analysis.

8 CI, 1.03-1.74; P = 0.02) in propensity score-adjusted analysis.

9 ly associated with cancer mortality in fully adjusted analysis.

10 ) in East Europe compared to South Europe in adjusted analysis.

11 between time to intubation and mortality in adjusted analysis.

12 lihood of hyperphosphatemia in multivariable-adjusted analysis.

13 pared with higher levels of each variable in adjusted analysis.

14 sians or Hispanics compared with NHWs in the adjusted analysis.

15 9, 95% CI 1.50-6.37, overall P=0.007) in the adjusted analysis.

16 and race-adjusted analysis to 0.89 in fully adjusted analysis.

17 found to be associated with infection in the adjusted analysis.

18 (34.4%; P=.04) by the prespecified covariate-adjusted analysis.

19 ]: 0.97 [0.71-1.31]) in the propensity score-adjusted analysis.

20 the odds of a complication (P < 0.001) in an adjusted analysis.

21 I, 1.59 to 3.71) compared with usual care in adjusted analysis.

22 interval [CI], 1.04-3.89) in a multivariable-adjusted analysis.

23 remained independent determinants of LVFP in adjusted analysis.

24 ciated with greater ICU-onset BSI risk after adjusted analysis.

25 (RR, .20; 95% CI, .09-.44; P < .0001) in the adjusted analysis.

26 DGF was similar on adjusted analysis.

27 irst 18 months of life in a propensity score-adjusted analysis.

28 in the superficial than deep cortex, even in adjusted analysis.

29 dropout and overall survival through a risk-adjusted analysis.

30 20-13.33]) were associated with blindness in adjusted analysis.

31 with all cognitive measures in multivariable-adjusted analysis.

32 ificantly lower in the intervention group in adjusted analysis.

33 d odds of nvAMD in unadjusted and confounder-adjusted analysis.

34 ations between GB and CPQ11-14 scores in the adjusted analysis.

35 nd 0.74 (0.46-1.20) for the propensity score-adjusted analysis.

36 ted only with higher risk of ESRD in a fully adjusted analysis.

37 , but the association was not significant in adjusted analysis.

38 cant comorbid conditions through matched and adjusted analysis.

39 and WRF on outcome was not significant in an adjusted analysis.

40 postoperative pressure ulcer development on adjusted analysis.

41 = 0.017); this difference did not persist in adjusted analysis: 0.79 (-0.22, 1.68; p = 0.057).

42 was higher in children in the WASH groups in adjusted analysis (1.81 [0.01, 3.61]).

43 ervention and control periods, respectively (adjusted analysis: 26.7/1,000 versus 26.2/1,000, adjuste

44 In adjusted analysis, 4.3% of EVARs and 18.5% of OARs had a

45 In adjusted analysis, a favorable response to therapy was i

46 In age-adjusted analysis, a longer duration of exercise episode

47 In adjusted analysis, a lower absolute lymphocyte count (AL

48 In the adjusted analysis, a re-KT was associated with a lower r

49 In adjusted analysis accounting for patient-level and hospi

50 In adjusted analysis, actual and physician-perceived patien

51 In adjusted analysis, adherence varied significantly by US

52 stimate was attenuated and nonsignificant in adjusted analysis (adjusted hazard ratio = 0.77, 95% con

53 ype seemed to be associated with worse OS on adjusted analysis (adjusted hazard ratio = 1.57; 95% CI,

54 gh this was not statistically significant in adjusted analysis (adjusted HR, 0.36; 95% CI, 0.05 to 2.

55 p = 0.02), and this difference persisted in adjusted analysis (adjusted odds ratio [AOR] = 0.51, 95%

56 talizations without cannabis use disorder in adjusted analysis (adjusted odds ratio, 1.19; 95% CI, 1.

57 In the adjusted analysis, age (beta=0.2 mL/m(2) per year, P<0.0

58 In an adjusted analysis, age, gender, racial ancestry, HIV-1 i

59 In adjusted analysis, all noncentral PICC tip locations-mid

60 On adjusted analysis, an independent association with a hig

61 dence interval], 8.7 [2.0-37.3]; P=0.004 for adjusted analysis and 3.4 [0.8-13.8]; P=0.07 for the una

62 as associated with increased mortality in an adjusted analysis and contained a distinct repertoire of

63 duce the likelihood of a worse outcome in an adjusted analysis and was associated with postoperative

64 In an adjusted analysis, at enrollment, increased maternal age

65 ared with participants without strabismus in adjusted analysis (B = -5.96, P < 0.001).

66 In adjusted analysis, baseline body composition measures we

67 In adjusted analysis, baseline factors associated with incr

68 In adjusted analysis, baseline factors associated with incr

69 In adjusted analysis, BAZ was associated with the following

70 In the adjusted analysis being under insulin treatment (OR = 3.

71 In the adjusted analysis, being non-Danish born (adjusted IR ra

72 requency repeated measures did not differ in adjusted analysis between groups post baseline (mean dif

73 In adjusted analysis, black patients were significantly les

74 In adjusted analysis, Black, Asian, and other races (eg, Am

75 In a demographic-adjusted analysis, blacks had a higher risk for all asse

76 In adjusted analysis, BMI was associated with lower odds of

77 ality plus HF hospitalization (>100 days) on adjusted analysis (both P>0.1).

78 In multivariable-adjusted analysis, both MASLD and fibrosis were associat

79 In pooled multivariable-adjusted analysis, both PDI and hPDI were inversely asso

80 In risk-adjusted analysis, both per-patient obstructive (hazard

81 In adjusted analysis, buildings using well water had 21% hi

82 I, 1.14-1.28) than were white patients in an adjusted analysis, but there were no significant racial

83 to the current practice of prospective risk-adjusted analysis by a National Surgical Quality Improve

84 Valid multivariable-adjusted analysis can be performed in distributed data n

85 In the adjusted analysis, cancer-screening rates were higher am

86 In an adjusted analysis, catheter-associated UTI rates decreas

87 In the adjusted analysis, CAZ-AVI increased the probability of

88 In the adjusted analysis, characteristics associated with decre

89 In adjusted analysis, children with nondilated CMP were at

90 A propensity score-weighted risk-adjusted analysis confirmed the early better survival as

91 s for both complications were significant in adjusted analysis (Cox regression).

92 In an adjusted analysis, CRP (HR 1.36; 95% CI 1.08, 1.71; P =

93 Adjusted analysis demonstrated a -4.7% (95% CI, -4.9% to

94 d 14.1% (95% CI, 10.8%-18.0%) of inpatients; adjusted analysis demonstrated a similar difference in i

95 An adjusted analysis demonstrated an inverse association be

96 Adjusted analysis demonstrated decreased mortality in th

97 >/=15 mm in thickness and in those with LGE; adjusted analysis demonstrated that segmental presence o

98 After an adjusted analysis designed to balance background prevale

99 In multivariate-adjusted analysis, diabetes remained unassociated with a

100 In multivariable adjusted analysis, dialysis during admission with IE was

101 In adjusted analysis, eligible patients with heart failure

102 In adjusted analysis, epitope spreading at baseline was ass

103 In adjusted analysis, experiencing homelessness (vs stable

104 In adjusted analysis, factors associated with multiple thre

105 In the adjusted analysis, factors associated with new smoking i

106 In multivariable-adjusted analysis, factors associated with prevalent ret

107 In adjusted analysis, factors independently associated with

108 In the fully adjusted analysis, female sex (odds ratio [OR] 0.87 [95%

109 ted in 29 (13%) patients; immortal time bias adjusted analysis found no significant difference betwee

110 ociated with higher in-hospital mortality in adjusted analysis (GFR, 60-89; odds ratio [OR], 1.5; 95%

111 In adjusted analysis, having detectable anti-S Ab was also

112 In crude and adjusted analysis (hazard ratio [HR], 0.49; 95% conficen

113 tality was observed for the entire cohort on adjusted analysis (hazard ratio, 0.99; 95% CI, 0.94-1.04

114 associated with cardiovascular events in an adjusted analysis (hazard ratio, 1.08; 95% confidence in

115 ot associated with risk for heart failure in adjusted analysis (hazard ratios, 1.0 [reference], 0.77

116 In adjusted analysis, HCV specialist assessment was associa

117 In adjusted analysis, HCV treatment was associated with non

118 In adjusted analysis, HCV treatment was lower among females

119 In this international, case-mix-adjusted analysis, higher annual hospital ECMO volume wa

120 In multivariate adjusted analysis, higher CD44 and TP levels were associ

121 In adjusted analysis, higher serum creatinine level, black

122 In adjusted analysis, higher-deductible plans were associat

123 In an adjusted analysis, HIV infection significantly increased

124 nterval [CI] 0.62 to 0.87; p < 0.001) and in adjusted analysis (HR 0.80, 95% CI 0.66 to 0.97; p = 0.0

125 This difference remained significant on adjusted analysis (HR 1.24, 95% CI 1.06-1.46).

126 e estimate was attenuated but significant in adjusted analysis (HR = 0.76, 95% CI = 0.61-0.94).

127 nce interval [CI]: 1.2-1.5) and multivariate-adjusted analysis (HR = 1.3; 95% CI: 1.1-1.5).

128 1 to 0.95; p < 0.001) and multivariable risk-adjusted analysis (HR per unit change for mortality risk

129 unders and established prognostic markers in adjusted analysis (HR, 0.95; P = .02).

130 or trend < 0.01) but not in the multivariate-adjusted analysis (HR: 1.09; 95% CI: 0.98, 1.21; P for t

131 y associated with type 2 diabetes in the age-adjusted analysis (HR: 1.91; 95% CI: 1.72, 2.11; P for t

132 Our adjusted analysis identified lymph node ratio, administr

133 rmore, the pattern of variation changed: the adjusted analysis identified three new outliers, and two

134 or of outcome for the composite end point in adjusted analysis III (hazard ratio=0.808; 95% CI, 0.689

135 In adjusted analysis, impaired CFR remained independently a

136 her systolic blood pressure was confirmed in adjusted analysis in the Chicago Genetics of Hypertensio

137 ve implantation devices were observed at the adjusted analysis in Valve Academic Research Consortium

138 In adjusted analysis, increases in MP were associated with

139 Adjusted analysis indicated greater likelihood of a pati

140 Adjusted analysis indicated that delirium, non-White rac

141 In an age-adjusted analysis, individuals with multiclonal P. falci

142 In adjusted analysis, injection drug use and homelessness w

143 In a multivariate-adjusted analysis, levels of fluorescent oxidation produ

144 In adjusted analysis, low-dose aspirin use was associated w

145 In adjusted analysis, low-income patients had 12-month FIT

146 ent predictors of the composite end point in adjusted analysis (LVH hazard ratio [HR], 3.0; 95% confi

147 In adjusted analysis, LVH was associated with increased ris

148 In the fully adjusted analysis, male nurses out-earned female nurses

149 In a multivariable-adjusted analysis, maternal total dietary intake (supple

150 In the adjusted analysis, mean serum hsCRP levels were signific

151 In adjusted analysis, median viral load set point and time

152 In adjusted analysis, men experienced higher rates of pacem

153 After adjusted analysis, mortality decreased throughout the st

154 In the adjusted analysis, mortality increased linearly with eac

155 However, in adjusted analysis, myocarditis was not associated with w

156 In the adjusted analysis, neither of these covariates remained

157 In single-SNP adjusted analysis, nine SNPs in the XPC, CYP2C9, PAX4, M

158 After adjusted analysis, no difference in odds of TRD for pati

159 In adjusted analysis, non-adherence to antibiotic choice [R

160 In adjusted analysis, non-Hispanic Black (aOR=0.78, 95% CI=

161 In adjusted analysis, non-Hispanic Black decedents (odds ra

162 sociated with 30-day readmission; in a fully adjusted analysis, none of the 9 SDOH were individually

163 ifferentially abundant in aoCRC vs. eoCRC in adjusted analysis (Odds Ratio = 21.8, FDR P = 0.04).

164 ociated with decreased odds of death in site-adjusted analysis (odds ratio [OR] 0.82 [95% CI 0.71-0.9

165 6%]; P = 0.06) and increased mortality in an adjusted analysis (odds ratio of 5.85; 95% confidence in

166 vorable neurocognitive outcome in propensity-adjusted analysis (odds ratio, 1.61; 95% confidence inte

167 We performed a propensity-adjusted analysis of a two-center retrospective cohort o

168 A baseline score-adjusted analysis of covariance model using effect-coded

169 nicity and diabetes risk using multivariable-adjusted analysis of covariance models.

170 , we propose a method for age-sex population-adjusted analysis of disease severity in epidemics that

171 In adjusted analysis of postoperative outcomes controlling

172 In adjusted analysis of pretreatment PET-CT characteristics

173 (95% CI, 0.26-0.84; P = .01) for a covariate-adjusted analysis of propensity-matched data to 0.61 (95

174 In a risk-adjusted analysis of septic patients, calcium administra

175 In adjusted analysis of the subset, LTL change was associat

176 In adjusted analysis of the workplace programme, lower swit

177 In adjusted analysis, older age (>/=70 versus <50 years; ha

178 In multivariable-adjusted analysis, older age, male sex, prediabetes or d

179 On adjusted analysis, older age, nonelective surgery, histo

180 In adjusted analysis, only a non-statistically significant

181 In the adjusted analysis, only younger age (OR, 1.05 per month;

182 nificantly associated with stroke in the age-adjusted analysis (OR 1.38, 95% CI 1.03-1.85).

183 gnificantly associated with ASD in partially adjusted analysis (OR, 1.20; 95% CI, 1.06-1.36), but thi

184 In an adjusted analysis, organizations with an addiction medic

185 An age-adjusted analysis over the past 25 years shows that in w

186 V40) was significantly associated with OS on adjusted analysis ( P < .05).

187 , this effect could not be confirmed in risk-adjusted analysis (p = 0.641).

188 rtality based failure to rescue in the fully adjusted analysis (P<0.05); however, the extended stay b

189 In the pooled multivariable-adjusted analysis, participants who consumed >=5 serving

190 In adjusted analysis, patient factors associated with incre

191 In adjusted analysis, patients co-administered S. boulardii

192 In adjusted analysis, patients coadministered S. boulardii

193 In adjusted analysis, patients living in the lower 2 nSES q

194 In the adjusted analysis, patients that were younger, women, re

195 In adjusted analysis, patients who were Black (odds ratio [

196 In propensity-adjusted analysis, patients with de-escalation had lower

197 In adjusted analysis, patients with documented surrogate de

198 In adjusted analysis, patients with stage IIIA or IIIB NSCL

199 In an adjusted analysis, patients with telehealth visits were

200 In risk-adjusted analysis, per-patient obstructive CAD (hazard r

201 In adjusted analysis, pharmacotherapy type was not associat

202 nteraction.Measurements and Main Results: In adjusted analysis, PM(2.5) (CMAQ) (odds ratio [OR], 1.12

203 In age- and sex-adjusted analysis, PMR was associated with a significant

204 In the adjusted analysis, practicing FTPA 4-7 times/week was as

205 In the adjusted analysis, preexisting gastrointestinal anomalie

206 In the adjusted analysis, presence of an ID specialist was asso

207 d properly, then the resulting ascertainment-adjusted analysis produces parameter estimates that gene

208 In the adjusted analysis, rates of procedural cerebral infarcti

209 In the adjusted analysis, receiving EEN was associated with red

210 In adjusted analysis, recent IDU with needle/syringe sharin

211 In the adjusted analysis, Rectal-No-Chemo was associated with l

212 In adjusted analysis, reinfection/superinfection occurred m

213 this difference remained significant in the adjusted analysis (relapse rate ratio 1.27, P=0.0305).

214 density (reference group) in unadjusted and adjusted analysis, respectively.

215 and 1.06 (95% CI, 0.93 to 1.22) in the fully adjusted analysis restricted to women with depression.

216 be correctly modeled, then an ascertainment-adjusted analysis returns population-based parameter est

217 Adjusted analysis revealed that factors influencing surv

218 Risk-adjusted analysis revealed that minimally invasive RH wa

219 This risk-adjusted analysis revealed that only rest and exercise e

220 In age-adjusted analysis, risk increased for subjects who self-

221 In the adjusted analysis, RIV4 (RVE 13.3%, 95% CI 7.4%, 18.9%),

222 In the adjusted analysis, RIV4 (RVE, 13.3%; 95% CI, 7.4-18.9%),

223 and nonischemic cardiomyopathy groups after adjusted analysis (RR 0.99, 95% CI 0.86 to 1.15; p = 0.9

224 not present in those taking pravastatin (age-adjusted analysis: RR, 0.98; 95% CI, 0.47-2.04; P =.046

225 Three SNPs in the MGMT gene (adjusted analysis, rs3858300; unadjusted analysis, rs107

226 In MELD-adjusted analysis, sarcopenia was strongly associated wi

227 uary and May 2021 in Maryland, in regression-adjusted analysis, SARS-CoV-2 viruses carrying the spike

228 In adjusted analysis, severe (injury severity score >= 15)

229 However, in the adjusted analysis, severity of AD was the main factor as

230 The adjusted analysis showed a 20% (95% CI, 11-28%) relative

231 The results of the stratified, adjusted analysis showed a 36% reduction in IMR (0.64, 0

232 Baseline-adjusted analysis showed CTO revasc was associated with

233 Adjusted analysis showed no significant association betw

234 Adjusted analysis showed no significant differences in t

235 ort with ENE-negative disease, multivariable adjusted analysis showed nonsignificant improvements wit

236 Adjusted analysis showed similar results.

237 Adjusted analysis showed that children who were RSV posi

238 Adjusted analysis showed that dental caries increment ra

239 Adjusted analysis showed that refugees had a 2.00-fold i

240 Adjusted analysis showed that retransplantation, A- and

241 Adjusted analysis showed that the increased risk attribu

242 In adjusted analysis, significantly better survival was obs

243 On adjusted analysis, social determinants including age, ra

244 In adjusted analysis, spontaneous breathing during the firs

245 Adjusted analysis stratified by number of involved nodes

246 On adjusted analysis, taking 2 or more diabetes medications

247 2.29), and in the maximally (multivariate-) adjusted analysis the relative risk was 1.59 (95% CI: 1.

248 According to multivariable-adjusted analysis, the aHRs for SUD (2.33; 95% CI, 1.89-

249 In adjusted analysis, the chance of survival by income leve

250 In a multivariable-adjusted analysis, the Crs was independently associated

251 In adjusted analysis, the factor with the strongest effect

252 In multivariable adjusted analysis, the hazard of death decreased signifi

253 In adjusted analysis, the highest (vs lowest) quartile of p

254 In adjusted analysis, the HO-CDI rate did not differ signif

255 In multivariable adjusted analysis, the increase in the odds per year of

256 In the adjusted analysis, the mortality rate was 16 percent low

257 In adjusted analysis, the odds of ED/Hosp use increased wit

258 In a sex-, race-, and age-adjusted analysis, the odds ratio for having low serum v

259 In adjusted analysis, the reduction in DTN time within 1 qu

260 In the adjusted analysis, the risk of developing OA was reduced

261 In adjusted analysis, the risk of posttransplant graft loss

262 In an adjusted analysis, the VLCD group lost 2.8 kg (95% CI: 2

263 s (95% PI, 6.0-9.3 percentage points) in the adjusted analysis; the excess death rate among Republica

264 In age-adjusted analysis, there was a decrease in risk for wome

265 In the adjusted analysis, there was a dose-dependent associatio

266 In the adjusted analysis, there was an association between each

267 Compared with 1-<2 years of use, in adjusted analysis, there was no association between CCB

268 In adjusted analysis, there was no difference in death-cens

269 In adjusted analysis, there was no difference in ICU readmi

270 In adjusted analysis, there was no difference in mortality

271 In the adjusted analysis, there was no difference in the SOFA c

272 Cox-regression analysis demonstrated that in adjusted analysis those in the N-SLK group were signific

273 In PS-quintile-adjusted analysis, those on newer DMTs had a lower relap

274 In the adjusted analysis, those walking (adjusted risk ratio [A

275 In onset-to-puncture adjusted analysis, time-outcome relationships were nonli

276 education changed from 0.79 in age- and race-adjusted analysis to 0.89 in fully adjusted analysis.

277 However, in a propensity score-adjusted analysis to account for baseline differences be

278 In final adjusted analysis, treatment group participants had 3.7

279 In adjusted analysis, two SNPs (rs2756109 [ABCC2] and rs952

280 associated with incident T2D in multivariate-adjusted analysis until body mass index was adjusted: od

281 In adjusted analysis, vaccination was associated with a red

282 In seasonally adjusted analysis, variation in both baseline and respir

283 In adjusted analysis, ventricular fibrillation patients dur

284 An age-adjusted analysis was performed for each variable to cal

285 A risk-adjusted analysis was performed to assess the effect of

286 An adjusted analysis was performed, using a multivariate re

287 were pooled with a random-effects model and adjusted analysis was performed.

288 Because ATH were younger, adjusted analysis was undertaken in younger HCM patients

289 In an adjusted analysis, we analyzed risk of heart failure (HF

290 associated with multiple acts of violence in adjusted analysis were male gender (OR, 3.37; 95% CI, 1.

291 In adjusted analysis, when compared with usual care, mean p

292 5-0.82, P < 0.001) had lesser Star scores on adjusted analysis, whereas patients with a cancer diagno

293 A propensity score-adjusted analysis, which included patient demographics,

294 ormed within the overall cohort and using an adjusted analysis with 1:1 propensity score matching for

295 HR], 1.60; 95% CI, 1.04-2.47; p = 0.033) and adjusted analysis with overlap weighting (adjusted HR, 1

296 2-way analysis of variance mixed-effects sex-adjusted analysis with post hoc Sidak correlation for mu

297 Risk-adjusted analysis without transfused PRBC in the model s

298 In adjusted analysis, women appeared to fill more warfarin

299 The adjusted analysis yielded the following OR (95%CI) for:

300 r incidence of HF, and this held true in the adjusted analysis yielding a hazard ratio of 1.54 (95% c